Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2012; 18(14): 1602-1609
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1602
Published online Apr 14, 2012. doi: 10.3748/wjg.v18.i14.1602
Figure 6 Effect of inhibitor, pyrrolidinedithiocarbamate, on basic fibro-blast growth factor protein expression.
Administration of pyrrolidinedithiocarbamate (PDTC) (50 μmol/L) reinforced the toxicarioside A (4.5 μg/mL)-induced downregulation of basic fibroblast growth factor (bFGF). Results are depicted as mean ± SE of three independent experiments. aP < 0.05 vs control group.
-
Citation: Guo JL, Zheng SJ, Li YN, Jie W, Hao XB, Li TF, Xia LP, Mei WL, Huang FY, Kong YQ, He QY, Yang K, Tan GH, Dai HF. Toxicarioside A inhibits SGC-7901 proliferation, migration and invasion
via NF-κB/bFGF signaling. World J Gastroenterol 2012; 18(14): 1602-1609 - URL: https://www.wjgnet.com/1007-9327/full/v18/i14/1602.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i14.1602